Jump to content

💙 HEAVY METAL LOVER T-SHIRT 💚

Follow Gaga Daily on Telegram
celeb

Kelly Clarkson addresses her weight loss and Ozempic rumors


Teletubby
 Share

Featured Posts

The Z
2 hours ago, SharGaga said:

But it's exactly what she said sis. I had an overweight cousin who had high chances of being diabetic so he dropped the weight and is no longer at risk. Are you a doctor?

Calm down girl lmao it seems you didn’t read the rest

Link to post
Share on other sites

TheEdgeof96
3 hours ago, HotLikeMexico said:

“Who are you to define “people who actually need it”?”- are you supposed to be the spokesperson?

I was specifically talking about Ozempic. There have been plenty of articles about these shortages affecting people with diabetes who can’t get their medication, and are still having issues getting it today. How is that not ****ed up?

You are assigning blame to people using medications for weight loss rather than manufacturers who are prioritizing onboarding new patients over existing.  You are wrong at the wrong thing. Because AGAIN. The weight loss versions of GLP-1 medications are only labeled for obesity (though Wegovy now is approved for heart conditions as well).
 

Insurance companies will only cover Ozempic/Mounjaro if the insured has Type II diabetes, and they will only cover Wegovy/Zepbound for patients who do NOT have TTD. Out of pocket, the manufacturer’s coupons are also only supported based on diabetes status and weight, meaning someone without diabetes would be paying $1k+/month for Ozempic/Mounjaro as they receive no discounts. This is a very niche group of people who could possibly afford that, and again, with the release of obesity-focused labels patients previously prescribed the TTD drugs have almost entirely moved to the obesity drugs so they are not monopolizing the supply or causing shortage of TTD drugs. 
 

I never said I’m the spokesperson, either. I’m someone who is using a GLP-1 medications for weight loss—as it is intended to be prescribed for and approved by the FDA—and sharing my own experience and that of people I know. Your responses towards me and in this chain are exactly why many people choose not to disclose their use of medications, and very likely why Kelly Clarkson withheld disclosing for so long and still won’t make the actual drug she’s used. 
 

Finger Shut Up GIF by Cody Simpson

  • Like 1
Link to post
Share on other sites

TheEdgeof96

Also, some reading material for anyone interested in the GLP-1 shortage or blaming the shortage on weight loss usage.

Directly from the article: "Lilly has opted to continue to allow new patients to start on Zepbound, rather than attempting to limit the supply to current users, something that Novo Nordisk did last year at the height of Wegovy’s shortage by restricting the supply of the lowest dose. Limiting this so-called starter dose meant that many new patients could not start treatment with Wegovy."

The main issues are:

1) Eli Lilly is prioritizing Zepbound (WL) production over Mounjaro (TTD)

2) Eli Lilly is prioritizing starter dose (2.5mg) production of both Zepbound & Mounjaro - meaning they are prioritizing the onboarding of new patients rather than prioritizing production of therapeutic doses (5, 7.5, 10, 12.5, 15 mg) of both Zepbound & Mounjaro, so existing patients cannot find their current dose. Then, due to increase volume of patients on starter doses looking to move to higher doses, there is now a higher volume of patients seeking higher doses when EL already cannot meet current demand

3) Manufacturing shortage is caused by inability to produce enough of the auto-injection pens they use for Zepbound & Mounjaro--not a shortage of the medication itself. Eli Lilly has FDA approval to release both Zepbound & Mounjaro via a single-use vial (like diabetics receive for insulin) which would be injected via a syringe rather than the auto-injection pens. However, Eli Lilly refuses to release the vials--it's likely that they are using the FDA approval to incentive their manufacturer to produce pens more quickly. It's also believed they're withholding vials as there is fear of revenue impact if patients were to split doses to make the drug last longer. I.e., instead of being prescribed 4 5-mg vials and injecting 5-mg/week, a patient could theoretically be prescribed 10-mg and receive 4 10-mg vials. They could then only inject half a vial each week, effectively then receiving 5-mg doses but it would last for 8 weeks rather than the 4 weeks a 5-mg prescription would last. All doses of Zepbound/Mounjaro cost the same to patients/insurers so for patients paying out of pocket or with a high deductible, they could be highly incentivized to pace their usage via vials more so than they can currently (which would "hurt" Eli Lilly's bottom line).

In case it still is not clear - the shortage is 100% caused by (shocking, I know!) pharmaceutical company greed. 

 

 

Link to post
Share on other sites

Cameltoe Chariot
4 hours ago, Gaga2645 said:

But I do think the Ozempic craze is kinda sh*tty to diabetics who need the medication having to suffer at the hands of a shortage due to the elite exercising their privileges. They have so many other avenues to lose weight easily without working for it they HAVE to use the avenue that’s a medication for diabetics? 

I get what you're saying but imagine if someone complained about obese people hogging food while children starve in third world countries? It all boils down to it being none of our business what people do with their own bodies. If there truly are shortages that's on both governments and manufacturers to meet demand. My Aunt is nowhere near "elite" and she's using ozempic for weight loss after other methods have failed her.

  • Like 1
Link to post
Share on other sites

Gaga2645
7 minutes ago, Cameltoe Chariot said:

I get what you're saying but imagine if someone complained about obese people hogging food while children starve in third world countries? It all boils down to it being none of our business what people do with their own bodies. If there truly are shortages that's on both governments and manufacturers to meet demand. My Aunt is nowhere near "elite" and she's using ozempic for weight loss after other methods have failed her.

If your aunt isn’t elite then the boot of what I was talking about doesn’t fit/concern her (saying this lightly ofc not trying to sound bitchy)-  I’m purely talking/complaining about celebrities doing it mainly. They’re celebrities and they kind of signed up for open discussion lol. And while yes it boils down to people minding their business about what people do with their bodies - I only felt the need to address what I was talking about because it comes across as if there’s a bit of a double standard if someone is fat and happy vs thin and happy. I don’t understand why the two cannot co exist.

  • Like 2
Link to post
Share on other sites

LukiiGleek

shes theeeee vocal goddess :) love her
Who cares how she lost weight. if it helps and keeps her healthy thats awesome. Plus she looks so good 

Link to post
Share on other sites

HotLikeMexico
Posted (edited)
15 hours ago, TheEdgeof96 said:

You are assigning blame to people using medications for weight loss rather than manufacturers who are prioritizing onboarding new patients over existing.  You are wrong at the wrong thing. Because AGAIN. The weight loss versions of GLP-1 medications are only labeled for obesity (though Wegovy now is approved for heart conditions as well).
 

Insurance companies will only cover Ozempic/Mounjaro if the insured has Type II diabetes, and they will only cover Wegovy/Zepbound for patients who do NOT have TTD. Out of pocket, the manufacturer’s coupons are also only supported based on diabetes status and weight, meaning someone without diabetes would be paying $1k+/month for Ozempic/Mounjaro as they receive no discounts. This is a very niche group of people who could possibly afford that, and again, with the release of obesity-focused labels patients previously prescribed the TTD drugs have almost entirely moved to the obesity drugs so they are not monopolizing the supply or causing shortage of TTD drugs. 
 

I never said I’m the spokesperson, either. I’m someone who is using a GLP-1 medications for weight loss—as it is intended to be prescribed for and approved by the FDA—and sharing my own experience and that of people I know. Your responses towards me and in this chain are exactly why many people choose not to disclose their use of medications, and very likely why Kelly Clarkson withheld disclosing for so long and still won’t make the actual drug she’s used. 
 

Finger Shut Up GIF by Cody Simpson

 
Wow, real mature at the end 

Yeah, we aren’t going to agree. Good on you for using what you want, I really don’t care and could care less what you do. However, I’m not going to agree on the idea of rich people exercising their privilege and taking things from people who need it. And neither will I agree with the doings of pharmaceutical companies allowing this. 

Edited by HotLikeMexico
Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
 Share


×
×
  • Create New...